Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

Microbot Medical says its LIBERTY robotic system has officially moved from limited release into full commercial operations, and the early ramp looks strong. The company reports that mid‑Q2 revenue has already surpassed all of Q1 as more hospitals begin using the system and existing sites increase procedure volume.

LIBERTY is now commercially active in six states — Georgia, Florida, New York, Michigan, Massachusetts, and North Carolina — with Boston becoming the first city to have multiple active accounts. According to the company, customer sites more than doubled once the limited rollout ended, and two of the three pivotal trial locations have already converted into paying commercial users.

They’re also highlighting a string of early clinical wins across different specialties, including robotic PAE for BPH, robotic GAE for knee pain, and robotic Y‑90 mapping and treatment for liver cancer. The company is framing these as proof that LIBERTY isn’t just novel tech — it’s being used in real procedures with real demand behind it!

Exciting stuff!

\_\_\_\_\_\_\_\_\_\_\_\_\_

**EDIT**: You'll notice the price is down 20% this morning. White Diamond Research released a hit piece 30 minutes after the good news and has a bot on MBOT\_Stock subreddit, spreading fud. If you want a fantastic buying opportunity, now is the time. No negative news has been released since FDA approval. The price has come down from stock dilution which is normal for a small cap biotech company. This stock will FLY once retail realizes this was a bullshit fud/hit piece